Topical Application of KAJD Attenuates 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis Symptoms Through Regulation of IgE and MAPK Pathways in BALB/C Mice and Several Immune Cell Types

Atopic dermatitis (AD) is a frequent skin complication that is caused by unknown reasons. KHU-ATO-JIN-D (KAJD) is a new drug aimed at AD composed of a mixture of extracts from six plants known to have anti-inflammatory and antiallergic effects. This study investigated whether KAJD alleviates 2,4-din...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Se Hyang, Ku, Jin Mo, Kim, Hyo In, Kim, Tai Young, Seo, Hye Sook, Shin, Yong Cheol, Ko, Seong-Gyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761305/
https://www.ncbi.nlm.nih.gov/pubmed/31607928
http://dx.doi.org/10.3389/fphar.2019.01097

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6761305/
https://www.ncbi.nlm.nih.gov/pubmed/31607928
http://dx.doi.org/10.3389/fphar.2019.01097

Ejemplares similares